Last updated on February 2018

Efficacy of Low-dose Dexmedetomidine to Prevent Delirium in Liver Transplant Patients


Brief description of study

To test the effect of low-dose dexmedetomidine for lowering the incidence of postoperative delirium in liver transplant patients in the ICU.

Single center prospective randomized placebo controlled clinical trial 0.1mcg/kg/hr of dexmedetomidine or equivalent amount of saline infusion started after induction of anesthesia for liver transplantation and continued until 48 hours after surgery.

Outcomes will be assessed up to 1 week or transfer to ward, whichever comes first.

Clinical Study Identifier: NCT02245256

Contact Investigators or Research Sites near you

Start Over

Seoul National University Hospital

Seoul, Korea, Republic of
8.47miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.